Evidence map›Paper›PMID 29277561›Full record

ArticleGastroenterology2018

Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.

Benoit Pourcet, Mathilde Zecchin, Lise Ferri, Justine Beauchamp, Sadicha Sitaula, Cyrielle Billon, Stéphane Delhaye, Jonathan Vanhoutte, Alicia Mayeuf-Louchart, Quentin Thorel and 10 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed, 1 synthesis or guideline pooled it, 210 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Benoit PourcetUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France. Electronic address: benoit.pourcet@pasteur-lille.fr.
Mathilde ZecchinUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Lise FerriUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Justine BeauchampUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Sadicha SitaulaDepartment of Pharmacology and Physiology, Saint Louis University School of Medicine, St Louis, Missouri.
Cyrielle BillonDepartment of Pharmacology and Physiology, Saint Louis University School of Medicine, St Louis, Missouri.
Stéphane DelhayeUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Jonathan VanhoutteUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Alicia Mayeuf-LouchartUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Quentin ThorelUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Joel T HaasUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St Louis, Missouri; The Scripps Research Institute, Jupiter, Florida.
Jérome EeckhouteUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
David DombrowiczUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Christian DuhemUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Alexis BoulinguiezUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Steve LancelUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Yasmine SebtiUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Thomas P BurrisDepartment of Pharmacology and Physiology, Saint Louis University School of Medicine, St Louis, Missouri; The Scripps Research Institute, Jupiter, Florida.
Bart StaelsUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France.
Hélène M DuezUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000, Lille, France. Electronic address: helene.duez@pasteur-lille.fr.
Inserm · FRSaint Louis University · USScripps Research Institute · US

Funding

REV-ERB ligands for treatment of anxiety disordersR01MH093429 · NIMH · SCRIPPS FLORIDA · PI BURRIS, THOMAS P · 2012 to 2016
$3.6M
NIMH NIH HHS R01 MH093429
6 · The paper itself

Abstract

BACKGROUND &

aimsThe innate immune system responds not only to bacterial signals, but also to non-infectious danger-associated molecular patterns that activate the NLRP3 inflammasome complex after tissue injury. Immune functions vary over the course of the day, but it is not clear whether these changes affect the activity of the NLRP3 inflammasome. We investigated whether the core clock component nuclear receptor subfamily 1 group D member 1 (NR1D1, also called Rev-erbα) regulates expression, activity of the NLRP3 inflammasome, and its signaling pathway.

methodsWe collected naïve peritoneal macrophages and plasma, at multiple times of day, from Nr1d1

resultsIn peritoneal macrophages, expression of NLRP3 and activation of its complex varied with time of day (circadian rhythm)-this regulation required NR1D1. Primary macrophages from Nr1d1

conclusionsIn studies of Nr1d1

Indexed as

Circadian RhythmAnimalsCaspase 1Cells, CulturedChemical and Drug Induced Liver InjuryCytokinesDisease Models, AnimalGalactosamineGenetic Predisposition to DiseaseInflammasomesLipopolysaccharidesLiverLiver Failure, AcuteMacrophage ActivationMacrophages, PeritonealMice, KnockoutCaspase 1CytokinesGalactosamineInflammasomesLipopolysaccharidesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanNlrp3 protein, mouseNR1D1 protein, humanNr1d1 protein, mouseNuclear Receptor Subfamily 1, Group D, Member 1PyrrolidinesSR9009ThiophenesAcute Liver FailureBiological ClockImmune RegulationRev-erbα

Identifiers

PMID29277561
PMCPMC5892845
OpenAlexW2776687787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.